< 1 minute read
Oct. 1, 2021

LY3202626

low-dose CNS-penetrant BACE inhibitor 90% red. of CSF Aβ in Ph. II at 9.2 mg / discont. from opt. vs. CatD and dose red. of prior leads Journal of Medicinal Chemistry Eli Lilly, Indianapolis, US

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in